[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340486-105":59,"doc-detail-340486-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","radionuclide-labelled-nanoparticles-for-cancer-combination-therapy-a-review","Radionuclide-labelled nanoparticles for cancer combination therapy - a review","","Radionuclide therapy (RT) is widely applied to advanced local cancers, yet its effectiveness is constrained by cancer cell radiation resistance. Combination strategies seek to overcome tumor resistance by pairing RT with photothermal therapy (PTT), photodynamic therapy (PDT), chemotherapy (CMT), and immunotherapy, which can improve outcomes. Nanotechnology further advances combination therapy through nanostructure platforms that enhance surface area, enable passive/active targeting, and increase payload capacity and functional surface features, improving sensitivity and specificity. The review classifies RT, summarizes recent integrated combinations, and outlines challenges and opportunities for radionuclide-labelled nanoparticles.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/radionuclide-labelled-nanoparticles-for-cancer-combination-therapy-a-review/340486/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/radionuclide-labelled-nanoparticles-for-cancer-combination-therapy-a-review/340486.png","ImageObject",300,407,{"name":92,"@type":93},"Seraphina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is radionuclide therapy (RT) combined with other treatments?","Question",{"text":113,"@type":114},"RT effectiveness can be limited by cancer cells’ radiation resistance, and non-specific distribution and damage to non-target organs further restrict outcomes. Combining RT with other modalities aims to bypass resistance and improve treatment performance.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How do radionuclide-labelled nanoparticles improve combination cancer therapy?",{"text":118,"@type":114},"Nanoparticles provide increased surface area, enable passive and active targeting, and offer high payload capacity. Surface modification and appropriate sizing can prolong circulation and improve accumulation and retention in tumor tissues while reducing toxicity to normal organs.",{"name":120,"@type":111,"acceptedAnswer":121},"Which combination therapy approaches are highlighted in the review?",{"text":122,"@type":114},"The review focuses on integrating RT with photothermal therapy (PTT), photodynamic therapy (PDT), chemotherapy (CMT), and immunotherapy, and it also discusses related design strategies such as tumor microenvironment regulation and radiosensitization using high-Z nanoparticles.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},340486,1790783203,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":26,"preview_page_count":19,"preview_urls":146},962075114101,"https://ap-avatar.wpscdn.com/avatar/e000253a75eb197efd?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780044092746381165","Sun et al. Journal of Nanobiotechnology (2024) 22:728  \n[https://doi.org/10.1186/s12951-024-03020-3](https://doi.org/10.1186/s12951-024-03020-3)  \nJournal of Nanobiotechnology  \n REVIEW Open Access  \nRadionuclide-labelled nanoparticles for cancer combination therapy: a review  \nNa Sun1, Tao Wang1 and Song Zhang1*  \nAbstract  \nRadionuclide therapy (RT) is widely used to advanced local cancers. However, its therapeutic efficacy is limited to the radiation resistance of cancer cells. Combination therapy aims to circumvent tumor resistance, and the combination of RT with photothermal therapy (PTT), photodynamic therapy (PDT), chemotherapy (CMT), and immunotherapy has shown promising treatment outcomes. Nanotechnology holds promise in advancing combination therapy by integrating multiple therapies on a nanostructure platform. This is due to the increased surface area, passive/active targeting capabilities, high payload capacity, and enriched surface of nanomedicines, offering significant advantagesin treatment sensitivity and specificity. In the first part of this review, we categorize radionuclide therapy. The second part summarizes the latest developments in combination therapies, specifically focusing on the integration of RT with PTT, PDT, CMT and immunotherapy. The last part provides an overview of the challenges and potential opportunities related to radionuclide-labelled nanoparticles for cancer combination therapy.  \nKeywords Radionuclides, Nanoparticles, Combination therapy  \n*Correspondence: Song Zhang [xqhyxzs@163.com](xqhyxzs@163.com)  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/.)[.](http://creativecommons.org/licenses/by-nc-nd/4.0/.)  \nSun et al. Journal of Nanobiotechnology (2024) 22:728 Page 2 of 24  \nGraphical Abstract  \nIntroduction  \nThe global annual cancer mortality has recently reached approximately 10 million, with projections indicating arise to 22 million by 2035 [1] . The traditional methods for clinical cancer treatment mainly include surgery, chemotherapy, and radiotherapy. Surgery can directly remove obvious solid tumors, but lacks precision incompletely eradicating residual cancer cells or tissues. Moreover, some patients are physically weak and unable to undergo surgical intervention. Chemotherapy has systemic therapeutic effects, but also has systemic toxicity and significant side effects [2] . For advanced cancer, 50–70% of patients undergo radiotherapy. Radionuclide therapy uses ionized atoms and free radicals released by radionuclides to cleave single stranded DNA, thereby inducing cancer cell apoptosis [3] . In addition, radionuclides can be used for single photon emission computed tomography (SPECT) [4] and positron emission tomography (PET) [5, 6], which are the  \nmain methods for diagnosing tumors and metastases.  \nRadionuclide therapy faces the following challenges: certain types of cancer are insensitive to RT, non-specific distribution hinders bioavailability","cbCaicVdi0EyymgV","https://ap.wps.com/l/cbCaicVdi0EyymgV","pdf",2121528,24,"English","# Introduction\n## Radionuclide therapy and clinical context\n## Rationale for combination therapy\n## Nanotechnology-enabled radionuclide delivery\n## Tumor microenvironment modulation\n## Radiosensitization using high-Z nanoparticles\n# Review structure and recent developments\n## Integration of RT with PTT, PDT, CMT, and immunotherapy\n## Challenges and opportunities","[{\"question\":\"Why is radionuclide therapy (RT) combined with other treatments?\",\"answer\":\"RT effectiveness can be limited by cancer cells’ radiation resistance, and non-specific distribution and damage to non-target organs further restrict outcomes. Combining RT with other modalities aims to bypass resistance and improve treatment performance.\"},{\"question\":\"How do radionuclide-labelled nanoparticles improve combination cancer therapy?\",\"answer\":\"Nanoparticles provide increased surface area, enable passive and active targeting, and offer high payload capacity. Surface modification and appropriate sizing can prolong circulation and improve accumulation and retention in tumor tissues while reducing toxicity to normal organs.\"},{\"question\":\"Which combination therapy approaches are highlighted in the review?\",\"answer\":\"The review focuses on integrating RT with photothermal therapy (PTT), photodynamic therapy (PDT), chemotherapy (CMT), and immunotherapy, and it also discusses related design strategies such as tumor microenvironment regulation and radiosensitization using high-Z nanoparticles.\"}]","Radionuclide-labelled nanoparticles for cancer combination therapy - a review | PDF",1790036838,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/07c2aed710732ba77f6efd861535ec19.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3a853086bdd5127a98323dfc50c1f0f2.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4acab283cec356f4cc8823635ef456e7.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/52c648a1c6f279ecbe20ac7a64e277ee.webp",980,1301]